Sippel, Anna
Riemann-Lorenz, Karin
Scheiderbauer, Jutta
Kleiter, Ingo
Morrison, Rebecca
Kofahl, Christopher
Heesen, Christoph
Funding for this research was provided by:
Roche Pharma
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 19 February 2021
Accepted: 7 September 2021
First Online: 22 October 2021
Declarations
:
: This study has been performed in accordance with the Declaration of Helsinki and has been approved by the ethical committee of the Hamburg Chamber of Physicians (approval number: PV5770). Written informed consent to participate in the study was obtained from all pwMS.
: Not applicable.
: AB has received funding from Roche. CH has received research grants, congress travel compensations and salaries for talks from Biogen, Genzyme, Sanofi-Aventis, Bayer Healthcare, Merck, Teva, Roche, and Novartis. IK has received speaker honoraria and travel funding from Bayer, Biogen, Novartis, Merck, Sanofi Genzyme, Roche; speaker honoraria from Mylan; travel funding from the Guthy-Jackson Charitable Foundation; consulted for Alexion, Bayer, Biogen, Celgene, Chugai, IQVIA, Novartis, Merck, Roche; and received research support from Chugai, Diamed. KRL, CK, JS, and RM declare having no competing interests.